F.M. Yavitt, B.E. Kirkpatrick, M.R. Blatchley, K.F. Speckl, E. Mohagheghian, R. Moldovan, N. Wang, P.J. Dempsey and K.S. Anseth, “In situ modulation of intestinal ...

Newcells Biotech (“Newcells”), a leading drug discovery partner specializing in the development of in vitro models and ...

The enzyme protein kinase N (PKN) has been implicated in a signaling cascade that causes heart fibroblast activation. A group ...

“It will allow the study of the intestinal stem cell in the context of the myofibroblast niche,” says Ootani, “and may also allow the interactions of stem cells with other cell types to be ...

HAYA is developing a pipeline of lncRNA-targeting candidates for the tissue-specific treatment of fibrotic diseases in ...

The gut microbiota and its functional metabolites play crucial roles in the development of intestinal fibrosis in patients ...

Lin Han obtained his BE degree from Tsinghua University in Beijing, P. R. China, and his PhD degree from the Massachusetts Institute of Technology in the area of Bio- and Polymeric Materials. After ...

Correspondence to Professor Paul William Hodges, Centre of Clinical Research Excellence in Spinal Pain, Injury and Health, School of Health and Rehabilitation Sciences, The University of Queensland, ...

As society ages, the number of patients with heart failure is rapidly increasing. Excessive growth of fibrotic tissue in the ...

Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 TrialInterim data from the ...

today announced the launch of its imaging suite and advanced lung Fibroblast-to-Myofibroblast Transition (FMT) assay. MicrosensDx is excited to announce that it is working with The Mayr Group at ...